ClinConnect ClinConnect Logo
Search / Trial NCT00743548

Comparing the Inter-dental Brush to Dental Floss

Launched by UNIVERSITY OF BRITISH COLUMBIA · Aug 28, 2008

Trial Information

Current as of May 13, 2025

Completed

Keywords

Interdental Self Care Aids Plaque Bleeding Gums

ClinConnect Summary

Purpose:

To determine if the interdental brush is just as effective at removing plaque and reducing bleeding gums between the teeth as dental floss.

Rationale:

Many people find dental floss difficult to use and thus, do not floss daily to maintain oral health and prevent gum disease. These individuals may find the interdental brush easier to use and may be motivated to use it daily for optimal oral health.

Study design:

Study subjects will use the dental floss AND the interdental brush for 12 weeks. Plaque and bleeding scores will be measured before the study begins (week 0), mid-way (...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults
  • Minimum of 4 interproximal areas that can accommodate a minimum 0.6 mm interdental brush width
  • Minimum of 8 interproximal bleeding sites upon stimulation
  • Dexterity to use manual waxed dental floss
  • Able to attend all 4 study visits
  • Exclusion Criteria:
  • Require premedication with antibiotics prior to dental therapy
  • Use chlorhexidine or over-the-counter mouthwash during the study
  • Smoke
  • Have orthodontia

About University Of British Columbia

The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.

Locations

Vancouver, British Columbia, Canada

Patients applied

0 patients applied

Trial Officials

Pauline Imai, MSc.

Principal Investigator

University of British Columbia

Penny Hatzimanolakis

Study Director

University of British Columbia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials